Drug Maker Nostrum, CEO Will Pay Up to $50 Million for Allegedly Underpaying Medicaid Rebates
- November 03, 2023
ARTICLE TAGS
You must be logged in to access this content.
Health Law Weekly
You must be logged in to access this content.